Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Directorate Changes

30 Jun 2025 07:00

RNS Number : 8596O
Synthomer PLC
30 June 2025
 

Synthomer plcDirectorate changes

 

Synthomer plc ('Synthomer' or the 'Group') today announces the appointment of two independent non-executive directors, Janet Ashdown and Jonathan Silver, who will join the Board on 1 July 2025.

 

Janet Ashdown has significant experience of general management primarily in the process and chemicals industries, as well as environmental and sustainability matters, and has chaired corporate remuneration committees for more than 10 years. Janet had a 30-year executive career at BP plc until 2010, running the UK retail and commercial fuel business in her last role there. She then became chief executive of Harvest Energy, an international private equity-backed business, until 2013. Janet is currently a non-executive director and remuneration committee chair at Victrex plc, a non-executive director and chair of the remuneration and corporate sustainability committees at RHI Magnesita plc and a non-executive director of Stolt-Nielsen plc. She has previously served as a non-executive director and remuneration committee chair of Marshalls plc and SIG plc, and as senior independent director and chair of committees including for health, safety, security and sustainability of the Nuclear Decommissioning Authority, a UK Government arm's length body. Janet holds a BSc in Energy Engineering from the University of Swansea. Janet will join the Synthomer Board's audit, remuneration and nomination committees on appointment and will succeed Holly Van Deursen as Chair of the Remuneration Committee in late 2026.

 

Jonathan Silver has significant international experience in finance and accounting, risk and controls, treasury, investment management and mergers and acquisitions, having served in a variety of senior roles culminating in chief financial officer during his 30-year executive career to 2015 at Laird plc. Prior to this Jonathan held finance roles at the pharmaceutical and agrichemicals group Fisons plc. Jonathan is currently non-executive director, senior independent director and audit committee chair at Spirent Communications plc. Jonathan also serves as a non-executive director and audit committee chair at Baillie Gifford China Growth Trust plc and at Henderson High Income Trust plc, and previously served in the same roles at Invesco Income Growth Trust plc. He is a Chartered Accountant and a member of the Institute of Chartered Accountants of Scotland. Jonathan holds a BA in Business from the University of Strathclyde. Jonathan will join the Synthomer Board's audit, remuneration and nomination committees on appointment and will succeed Ian Tyler as Chair of the Audit Committee later this year.

 

Further to the announcement of 5 March 2025, Ian Tyler will step down from the Board of Synthomer and his roles as Senior Independent Non-executive Director and Audit Committee Chair in December 2025.

 

Further information:

Investors: Faisal Tabbah, Vice President Investor Relations

Tel: +44 (0) 1279 775 306

Media: Nick Hasell, FTI Consulting

Tel: +44 (0) 203 727 1340

 

Notes

Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56. Classification as per DTR 6 Annex 1R: 3.1.

 

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection - growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed there since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia. With more than 6,000 blue-chip customers and £2.0bn in continuing revenue in 2024, our business is built around three divisions, serving customers in attractive end markets where demand is driven by global megatrends including urbanisation, demographic change, climate change and sustainability, and shifting economic power. In Coatings & Construction Solutions, our specialist polymers enhance the sustainability and performance of a wide range of coatings and construction products. We serve customers in applications including architectural and masonry coatings, mortar modification, waterproofing and flooring, fibre bonding, and energy solutions. In Adhesive Solutions our products help our customers bond, modify and compatibilise surfaces and components for applications including tapes and labels, packaging, hygiene, tyres and plastic modification, improving permeability, strength, elasticity, damping, dispersion and grip. In Health & Protection and Performance Materials we are a world-leading supplier of water-based polymers for medical gloves, and a major European manufacturer of high-performance binders, foams and other products serving customers in a range of end markets. Our purpose is creating innovative and sustainable solutions for the benefit of customers and society. Around 20% of our sales volumes are from new and patent protected products. At our innovation centres of excellence in the UK, China, Germany, Malaysia and Ohio, USA we collaborate closely with our customers to develop new products and enhance existing ones tailored to their needs, with an increasing range of sustainability benefits. Our 2030 decarbonisation targets have been approved by the Science Based Targets initiative as being in line with what the latest climate science says is necessary to meet the goals of the Paris Agreement, and since 2021 we have held the London Stock Exchange Green Economy Mark, which recognises green technology businesses making a significant contribution to a more sustainable, low-carbon economy. Find us at www.synthomer.com or search for Synthomer on LinkedIn.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKCBKPBKDNAB
Date   Source Headline
6th May 201011:00 amRNSInterim Management Statement
30th Apr 201012:40 pmRNSAnnual Information Update
8th Apr 20107:00 amRNSAnnual Financial Report
12th Mar 20107:00 amRNSDisposal
11th Mar 201010:32 amRNSDirector/PDMR Shareholding
11th Mar 201010:31 amRNSDirector/PDMR Shareholding
10th Mar 20107:00 amRNSFinal Results
11th Feb 201012:32 pmRNSHolding(s) in Company
4th Feb 201011:38 amRNSHolding(s) in Company
12th Jan 20107:00 amRNSTrading Update
25th Nov 200910:02 amRNSHolding(s) in Company
18th Nov 20099:28 amRNSHolding(s) in Company
19th Oct 20097:00 amRNSInterim Management Statement
2nd Sep 200910:14 amRNSHolding(s) in Company
24th Aug 20097:00 amRNSHalf Yearly Report
23rd Jun 20097:00 amRNSPre-close Trading Update
18th May 20099:16 amRNSDirector/PDMR Shareholding
14th May 200912:40 pmRNSResult of AGM
14th May 20097:00 amRNSAGM & Interim Management Statement
1st May 20097:00 amRNSAppointment of new joint brokers
21st Apr 20094:20 pmRNSAnnual Information Update
15th Apr 20099:24 amRNSAnnual Financial Report
23rd Mar 20094:03 pmRNSHolding(s) in Company
23rd Mar 20094:01 pmRNSHolding(s) in Company
20th Mar 200910:31 amRNSDirector/PDMR Shareholding
19th Mar 20097:00 amRNSAppointment of Senior Independent Director
16th Mar 20094:54 pmRNSDirector/PDMR Shareholding
12th Mar 20092:35 pmRNSDirector/PDMR Shareholding
12th Mar 20092:31 pmRNSDirector/PDMR Shareholding
11th Mar 20094:18 pmRNSDirector/PDMR Shareholding
11th Mar 20097:00 amRNSFinal Results
4th Mar 20094:35 pmRNSPrice Monitoring Extension
4th Mar 20091:57 pmRNSAppointment of non-executive director
13th Feb 20094:40 pmRNSSecond Price Monitoring Extn
13th Feb 20094:35 pmRNSPrice Monitoring Extension
30th Jan 20093:54 pmRNSNew Loan Facility / Completion of Disposal
21st Jan 20097:00 amRNSAppointment of new Chairman
19th Jan 20094:29 pmRNSDirector/PDMR Shareholding
15th Jan 20091:59 pmRNSDirector/PDMR Shareholding
13th Jan 200912:33 pmRNSHolding(s) in Company
7th Jan 20095:29 pmRNSDirector/PDMR Shareholding
5th Jan 200911:17 amRNSDisposal
29th Dec 20087:00 amRNSUpdate
12th Dec 200810:08 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSSale of PFW Aroma Chemicals BV
3rd Dec 200810:57 amRNSBlocklisting Interim Review
20th Nov 20084:47 pmRNSSecond Price Monitoring Extn
20th Nov 20084:39 pmRNSPrice Monitoring Extension
14th Nov 20087:00 amRNSInterim Management Statement
10th Nov 20083:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.